The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Pharmaceutical nanocrystals: production by wet milling and applications
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Theory of the Stability of Lyophobic Colloids.
Verwey, E. J. W. (1947) · The Journal of Physical and Colloid Chemistry · doi:10.1021/j150453a001 · Cited by 1,367
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
KECK, C., & MULLER, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.009 · Cited by 1,061
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Physical and chemical stability of drug nanoparticles
Wu, L., Zhang, J., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.001 · Cited by 993
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Handbook of Industrial Mixing: Science and Practice
(2003) · Wiley eBooks · doi:10.1002/0471451452 · Cited by 932
Shegokar, R., & Müller, R. H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.044 · Cited by 740
Van Eerdenbrugh, B., Van den Mooter, G., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 717
Müller, R. H., Gohla, S., & Keck, C. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.007 · Cited by 702
Merisko-Liversidge, E., & Liversidge, G. G. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.007 · Cited by 608
Comparative assessment of nanomaterial definitions and safety evaluation considerations
Boverhof, D. R., Bramante, C. M., Butala, J. H., Clancy, S. F., Lafranconi, M., West, J., & Gordon, S. C. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.06.001 · Cited by 443
Drug nanocrystals in the commercial pharmaceutical development process
Möschwitzer, J. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.034 · Cited by 432
Butler, J. M., & Dressman, J. B. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22217 · Cited by 427
On the Basic concept of Nanotechnology
Taniguchi, N. (1974) · Medical Entomology and Zoology · Cited by 423
Estimation of the aqueous solubility I: Application to organic nonelectrolytes
Jain, N., & Yalkowsky, S. H. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200102)90:2<234::aid-jps14>3.0.co;2-v · Cited by 375
Drug nanocrystals: in vivo performances.
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347
Physical stability of nanosuspensions: Investigation of the role of stabilizers on Ostwald ripening
Verma, S., Kumar, S., Gokhale, R., & Burgess, D. J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.027 · Cited by 304
Nanotherapeutics in the EU: an overview on current state and future directions
Pepic, I., Hafner, A., Lovric, J., & Perina Lakos, G. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55359 · Cited by 294
Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery
Brough, C., & Williams, R. O. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.061 · Cited by 288
Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability
Tuomela, A., Hirvonen, J., & Peltonen, L. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8020016 · Cited by 282
Wu, Y., Loper, A., Landis, E., Hettrick, L., Novak, L., Lynn, K., Chen, C., Thompson, K., Higgins, R., Batra, U., et al. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.001 · Cited by 275
Wong, J., Brugger, A., Khare, A., Chaubal, M., Papadopoulos, P., Rabinow, B., Kipp, J., & Ning, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.008 · Cited by 251
Engineered nanocrystal technology: In-vivo fate, targeting and applications in drug delivery
Pawar, V. K., Singh, Y., Meher, J. G., Gupta, S., & Chourasia, M. K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.030 · Cited by 250
A screening study of surface stabilization during the production of drug nanocrystals
Van Eerdenbrugh, B., Vermant, J., Martens, J. A., Froyen, L., Van Humbeeck, J., Augustijns, P., & Van den Mooter, G. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21563 · Cited by 242
Wet comminution in stirred media mills — research and its practical application
Kwade, A. (1999) · Powder Technology · doi:10.1016/s0032-5910(99)00113-8 · Cited by 232
Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., Li, X., & Wang, F. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0889-z · Cited by 227
Nanotoxicity: challenging the myth of nano-specific toxicity
Donaldson, K., & Poland, C. A. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.05.003 · Cited by 221
Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case Study
Chaubal, M. V., & Popescu, C. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9625-0 · Cited by 216
Formation, characterization, and fate of inhaled drug nanoparticles
Zhang, J., Wu, L., Chan, H.-K., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.002 · Cited by 210
Preparation of a chemically stable quercetin formulation using nanosuspension technology
Gao, L., Liu, G., Wang, X., Liu, F., Xu, Y., & Ma, J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.009 · Cited by 204
Computational prediction of formulation strategies for beyond-rule-of-5 compounds
Bergström, C. A. S., Charman, W. N., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.005 · Cited by 187
Pharmaceutical Amorphous Nanoparticles
Jog, R., & Burgess, D. J. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.09.014 · Cited by 186
Nanotherapies for the treatment of ocular diseases
Reimondez-Troitiño, S., Csaba, N., Alonso, M. J., & de la Fuente, M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.019 · Cited by 182
Poorly Soluble Marketed Drugs Display Solvation Limited Solubility
Bergström, C. A. S., Wassvik, C. M., Johansson, K., & Hubatsch, I. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0706416 · Cited by 170
The relationship between particle size and solubility
Buckton, G., & Beezer, A. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90184-4 · Cited by 143
Nanocrystals for the parenteral delivery of poorly water-soluble drugs
Sun, B., & Yeo, Y. (2012) · Current Opinion in Solid State and Materials Science · doi:10.1016/j.cossms.2012.10.004 · Cited by 132
Amorphous Drug Nanosuspensions. 3. Particle Dissolution and Crystal Growth
Lindfors, L., Skantze, P., Skantze, U., Westergren, J., & Olsson, U. (2007) · Langmuir · doi:10.1021/la700811b · Cited by 127
Solubility Increases Associated with Crystalline Drug Nanoparticles: Methodologies and Significance
Eerdenbrugh, B. V., Vermant, J., Martens, J. A., Froyen, L., Humbeeck, J. V., den Mooter, G. V., & Augustijns, P. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100209b · Cited by 120
Vidlářová, L., Romero, G. B., Hanuš, J., Štĕpánek, F., & Müller, R. H. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.05.004 · Cited by 120
Yang, W. P., Tam, J. M., Miller, D. A., Zhou, J., McConville, J. T., Johnston, K. P., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.003 · Cited by 112
Zhu, Z., Margulis‐Goshen, K., Magdassi, S., Talmon, Y., & Macosko, C. W. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22090 · Cited by 110
Shegokar, R., & Singh, K. K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.09.041 · Cited by 105
Development Considerations for Nanocrystal Drug Products
Chen, M., John, M. D., Lee, S. L., & Tyner, K. M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0064-x · Cited by 103
Sirolimus: A new agent for prevention of renal allograft rejection
Vasquez, E. M. (2000) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/57.5.437 · Cited by 96
Nanosuspension improves tretinoin photostability and delivery to the skin
Lai, F., Pireddu, R., Corrias, F., Fadda, A. M., Valenti, D., Pini, E., & Sinico, C. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.10.007 · Cited by 93
Niwa, T., Miura, S., & Danjo, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.013 · Cited by 90
Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former
Yamasaki, K., Kwok, P. C. L., Fukushige, K., Prud’homme, R. K., & Chan, H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.010 · Cited by 87
Nanocrystal for ocular drug delivery: hope or hype
Sharma, O. P., Patel, V. F., & Mehta, T. A. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0292-0 · Cited by 87
Yue, P., Li, Y., Wan, J., Yang, M., Zhu, W., & Wang, C. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.050 · Cited by 80
Pireddu, R., Caddeo, C., Valenti, D., Marongiu, F., Scano, A., Ennas, G., Lai, F., Fadda, A. M., & Sinico, C. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.026 · Cited by 77
A Review: Pharmaceutical and Pharmacokinetic Aspect of Nanocrystalline Suspensions
Shah, D. A., Murdande, S. B., & Dave, R. H. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24694 · Cited by 75
Tolman, J. A., & Williams, R. O. (2009) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903092319 · Cited by 64
Zhai, X., Lademann, J. M., Keck, C. M., & Müller, R. H. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.07.002 · Cited by 50
Ito, A., Konnerth, C., Schmidt, J., & Peukert, W. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.11.011 · Cited by 47
Avoidance of Generic Competition by Abbott Laboratories' Fenofibrate Franchise
Downing, N. S., Ross, J. S., Jackevicius, C. A., & Krumholz, H. M. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.187 · Cited by 38
Agglomerates of Ciprofloxacin Nanoparticles Yield Fine Dry Powder Aerosols
El-Gendy, N. A., Desai, V. M., & Berkland, C. J. (2010) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-010-9082-2 · Cited by 30
Britland, S. T., Finter, W., Chrystyn, H., Eagland, D., & Abdelrahim, M. E. A. (2012) · Biotechnology Progress · doi:10.1002/btpr.1616 · Cited by 21
Solid Nanosuspensions: The Emerging Technology and Pharmaceutical Applications as Nanomedicine
Verma, S., & Burgess, D. J. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1087-5_10 · Cited by 20
Polymeric Stabilizers for Drug Nanocrystals
Peltonen, L., Tuomela, A., & Hirvonen, J. J. (2015) · doi:10.1002/9781119041559.ch3 · Cited by 4
Cited by
Recent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability
Gigliobianco, M. R., Casadidio, C., Censi, R., & Di Martino, P. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030134 · Cited by 366
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
Nanocrystals: a perspective on translational research and clinical studies
Jarvis, M., Krishnan, V., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10122 · Cited by 162
Nanonization techniques to overcome poor water-solubility with drugs
Da Silva, F. L. O., Marques, M. B. D. F., Kato, K. C., & Carneiro, G. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1750591 · Cited by 136
Metadata
- Authors
- Malamatari, M., Taylor, K. M. G., Malamataris, S., Douroumis, D., & Kachrimanis, K.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 23
- Issue
- 3
- Pages
- 534-547
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2783618712
- Cited by
- 369
- References
- 59
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.